C
Coya Therapeutics D
D
COYA
7.32000
USD
0.07
(0.97%)
Market Open
Volume
442
EPS
0
Div Yield
0
P/E
-10
Market Cap
111,419,975
Novo Nordisk Surges in Profit and Sales
6 months ago
Stocks news More
Title: Coya Therapeutics
Sector: Healthcare
Industry: Biotechnology
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.